Will Pipeline Disasters Devour Eli Lilly & Co. (LLY) Stock?

Page 2 of 2

Foolish bottom line
I can’t give the company a free pass on soon-to-be plummeting revenue, but I can say that the pipeline probably holds a few big winners. Unfortunately for investors holding on to Eli Lilly stock, I just don’t see it beating out many of its Big Pharma peers. Other pharma companies have brighter immediate futures than Eli Lilly and have done quite well in preparing for the patent cliff. Shareholders of Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) will experience limited exposure to falling revenue, while it will be a more painful and prolonged process for Eli Lilly & Co. (NYSE:LLY) investors. Am I off the mark? Let me know in the comments section below.

The article Will Pipeline Disasters Devour Eli Lilly Stock? originally appeared on Fool.com.

Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio or his CAPS page, or follow him on Twitter, @BlacknGoldFool, to keep up with his writing on energy, bioprocessing, and emerging technologies.The Motley Fool recommends and owns shares of Johnson & Johnson.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Page 2 of 2